Sooma Medical develops portable neuromodulation systems designed to treat depression and chronic pain through non-invasive brain stimulation. The company’s platform is based on transcranial direct current stimulation (tDCS) and is intended for home use under clinical supervision. Its approach focuses on combining accessibility with structured therapeutic oversight. Sooma Medical positions its technology within regulated clinical treatment pathways.

The technology delivers controlled tDCS to targeted brain regions using a wearable device. Treatment protocols are configured and managed remotely by clinicians, enabling patients to complete sessions at home while maintaining clinical guidance. This remote management framework supports adherence, safety, and personalization of therapy. The system emphasizes simplicity and scalability without sacrificing clinical rigor.

Sooma Medical targets patients with depression and chronic pain who require non-pharmacological treatment options. The platform is intended to complement traditional care and reduce barriers to accessing neuromodulation therapy. Its positioning reflects broader efforts to expand mental health treatment through remotely managed, home-based brain stimulation systems.